| 1 |
Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects |
|
| | Kah Min Yap, Mahendran Sekar, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Lay Jing Seow, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria, Pei Teng Lum | | | Saudi Journal of Biological Sciences. 2021; 28(12): 6730 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics |
|
| | Guruprasadh Swaminathan, Aisha Shigna, Aviral Kumar, Vishnu Vardhan Byroju, Varsha Reddy Durgempudi, Lekha Dinesh Kumar | | | Frontiers in Nanotechnology. 2021; 3 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade |
|
| | Alireza Shoari, Raheleh Tooyserkani, Mehdi Tahmasebi, Dennis W. P. M. Löwik | | | Pharmaceutics. 2021; 13(9): 1391 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer |
|
| | Wioletta Rozpedek, Dariusz Pytel, Adam Wawrzynkiewicz, Natalia Siwecka, Adam Dziki, Lukasz Dziki, J. Alan Diehl, Ireneusz Majsterek | | | Current Cancer Drug Targets. 2020; 20(3): 223 | | | [Pubmed] [Google Scholar] [DOI] | |
|
